|
Continuous Wireless Monitoring of Vital Signs and Automated Alerts in Participants at Home and During Hospitalization
RECRUITINGSponsored by University Hospital Bispebjerg and Frederiksberg
Actively Recruiting
SponsorUniversity Hospital Bispebjerg and Frederiksberg
Started2021-02-01
Est. completion2025-06-27
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT05378139
Summary
The primary aim of this study is to test and assess the implementation and effectiveness of continuous wireless vital signs monitoring with real-time alerts on: The frequency of patients monitored with adequate data quality as adequate clinical user satisfaction in the initial versus the last part of the trial (primary outcome).
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: * Adult participants (≥18 years) * Patients assessed by the clinical staff as having an acute condition with risk for clinical deterioration and being either at home (with no apparent need for hospitalization), and/or in hospital OR * Patients at either at home before, in-hospital and/or after hospitalization for elective major surgery, defined as surgery lasting more than one hour under general- or regional anaesthesia Exclusion Criteria: * The participant expected not to cooperate with study procedures. * Allergy to plaster or silicone. * Having pacemaker or Implantable Cardioverter Defibrillator (ICD) device. * Inability to give informed consent.
Conditions9
CancerCardiac DiseaseHeart DiseaseHematologic DiseasesInfectionsLung CancerOncologyPulmonary DiseaseSurgical Complication
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorUniversity Hospital Bispebjerg and Frederiksberg
Started2021-02-01
Est. completion2025-06-27
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT05378139